VEA

Virtus ETF Advisers Portfolio holdings

AUM $75.7M
1-Year Return 23.01%
This Quarter Return
-0.88%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$227M
AUM Growth
-$15.9M
Cap. Flow
-$6.79M
Cap. Flow %
-2.99%
Top 10 Hldgs %
7.9%
Holding
407
New
8
Increased
60
Reduced
329
Closed
10

Top Buys

1
XFLT
XAI Octagon Floating Rate and Alternative Income Trust
XFLT
$663K
2
VTA
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$551K
3
FRA icon
BlackRock Floating Rate Income Strategies Fund
FRA
$469K
4
EFT
Eaton Vance Floating-Rate Income Trust
EFT
$425K
5
ENIC icon
Enel Chile
ENIC
$406K

Top Sells

1
GRA
W.R. Grace & Co.
GRA
$1.73M
2
BGX
Blackstone Long-Short Credit Income Fund
BGX
$731K
3
BGB
Blackstone Strategic Credit 2027 Term Fund
BGB
$693K
4
NOA
North American Construction
NOA
$569K
5
MCI
Barings Corporate Investors
MCI
$524K

Sector Composition

1 Healthcare 25.28%
2 Real Estate 19.7%
3 Energy 13.28%
4 Utilities 12%
5 Materials 10.51%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ENTA icon
126
Enanta Pharmaceuticals
ENTA
$193M
$545K 0.24%
9,599
-884
-8% -$50.2K
BSL
127
Blackstone Senior Floating Rate 2027 Term Fund
BSL
$186M
$540K 0.24%
32,875
-511
-2% -$8.39K
ADCT icon
128
ADC Therapeutics
ADCT
$391M
$536K 0.24%
19,728
-1,812
-8% -$49.2K
IRWD icon
129
Ironwood Pharmaceuticals
IRWD
$187M
$531K 0.23%
40,695
-3,726
-8% -$48.6K
NSL
130
DELISTED
NUVEEN SENIOR INCM FD
NSL
$531K 0.23%
90,768
-238
-0.3% -$1.39K
REGN icon
131
Regeneron Pharmaceuticals
REGN
$60.7B
$521K 0.23%
861
-83
-9% -$50.2K
ALNY icon
132
Alnylam Pharmaceuticals
ALNY
$59.1B
$518K 0.23%
2,745
-251
-8% -$47.4K
DSU icon
133
BlackRock Debt Strategies Fund
DSU
$547M
$518K 0.23%
44,911
-1,802
-4% -$20.8K
LGND icon
134
Ligand Pharmaceuticals
LGND
$3.29B
$517K 0.23%
5,954
-549
-8% -$47.7K
HRZN icon
135
Horizon Technology Finance
HRZN
$296M
$508K 0.22%
31,220
-1,580
-5% -$25.7K
JFR icon
136
Nuveen Floating Rate Income Fund
JFR
$1.13B
$508K 0.22%
50,430
-1,391
-3% -$14K
JRO
137
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$508K 0.22%
50,876
-1,822
-3% -$18.2K
GLAD icon
138
Gladstone Capital
GLAD
$583M
$501K 0.22%
22,180
-2,321
-9% -$52.4K
SGEN
139
DELISTED
Seagen Inc. Common Stock
SGEN
$497K 0.22%
2,925
-270
-8% -$45.9K
SRPT icon
140
Sarepta Therapeutics
SRPT
$1.99B
$491K 0.22%
5,311
-487
-8% -$45K
ONC
141
BeOne Medicines Ltd. American Depositary Shares
ONC
$37.1B
$482K 0.21%
1,328
-120
-8% -$43.6K
SAR icon
142
Saratoga Investment
SAR
$395M
$477K 0.21%
16,583
-4,060
-20% -$117K
PHD
143
Pioneer Floating Rate Fund
PHD
$123M
$476K 0.21%
41,443
-402
-1% -$4.62K
EFR
144
Eaton Vance Senior Floating-Rate Fund
EFR
$345M
$472K 0.21%
32,323
-425
-1% -$6.21K
BGT icon
145
BlackRock Floating Rate Income Trust
BGT
$316M
$471K 0.21%
35,477
-941
-3% -$12.5K
DCF
146
DELISTED
BNY Mellon Alcentra Global Credit Income 2024 Target Term Fund, Inc.
DCF
$471K 0.21%
49,720
+2,049
+4% +$19.4K
UTHR icon
147
United Therapeutics
UTHR
$17.6B
$470K 0.21%
2,548
-231
-8% -$42.6K
FRA icon
148
BlackRock Floating Rate Income Strategies Fund
FRA
$468M
$469K 0.21%
+35,109
New +$469K
GILD icon
149
Gilead Sciences
GILD
$141B
$469K 0.21%
6,710
-616
-8% -$43.1K
NKTR icon
150
Nektar Therapeutics
NKTR
$704M
$465K 0.2%
1,724
-159
-8% -$42.9K
4 5
6
7 8